Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Screening for Oculocerebral Lymphoma by Identifying the Phenotype Carried by Circulating NK Cells in Patients With Uveitis
NCT05388838Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2022
- Primary completion
- Mar 2025
- Countries
- 1
01
Overview
Trial (6 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Percentage of NK Cells in blood with phenotype acquired by trogocytosis at 1 year. Started Jun 2022; status: completed.
Beyond the preview
Go deeper on NCT05388838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05388838.